1. Home
  2. BGDE vs RNAZ Comparison

BGDE vs RNAZ Comparison

Compare BGDE & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Big Digital Energy Inc. Common Stock

BGDE

Big Digital Energy Inc. Common Stock

BUY

Current Price

$4.31

Market Cap

29.1M

Sector

Finance

ML Signal

BUY

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$1.68

Market Cap

27.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGDE
RNAZ
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.1M
27.9M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
BGDE
RNAZ
Price
$4.31
$1.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 76.3K
48.9K
Earning Date
11-13-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $39,754,085.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.35
$1.52
52 Week High
$11.69
$13.92

Technical Indicators

Market Signals
Indicator
BGDE
RNAZ
Relative Strength Index (RSI) 40.96 46.15
Support Level $4.79 $1.55
Resistance Level $6.48 $1.93
Average True Range (ATR) 0.44 0.17
MACD -0.02 0.07
Stochastic Oscillator 40.31 65.85

Price Performance

Historical Comparison
BGDE
RNAZ

About BGDE Big Digital Energy Inc. Common Stock

Big Digital Energy Inc, formerly Mawson Infrastructure Group Inc is focused on digital infrastructure platforms. It designs, builds and operates next-generation digital infrastructure platforms for enterprise customers and for its own purposes. The company provides services spanning AI, HPC, digital assets including Bitcoin mining, and other intensive compute applications. The company delivers both self-mining operations and colocation services to enterprise customers with a vertically integrated infrastructure model built for scalability and efficiency. The company also has an energy management business, which utilizes software and analysis, to generate revenue by participating in energy management programs. It operates as one energy management and digital asset mining segment.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: